Metraipolis › archive › dc_e209e25ae600

Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40963624
DOI
10.3389/fimmu.2025.1565803
License (as archived)
solo-consultazione
Archived
2026-11-10T04:22:37.374Z
SHA-256 of the archived text
eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945
Stable URL of this page
https://metraipolis.com/documento/dc_e209e25ae600

How to cite

Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624 — Europe PMC (en), https://europepmc.org/article/MED/40963624 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e209e25ae600 (Metraipolis archive dc_e209e25ae600, sha256 eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945)
BibTeX
@misc{dce209e25ae600,
  title = {Anti-MDA5+ dermatomyositis following SARS-COV-2 infections: a systematic review — Europe PMC PMID:40963624},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40963624},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e209e25ae600; sha256 eea6ed61da00ea233f18a7b0d01237f2c64ad86ac16d21c2ca007e3bda754945},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963624. Agents can read the archived copy with the MCP tool read_document.